New Therapeutic Options for Type 2 Diabetes Mellitus and Their Impact Against Ischemic Heart Disease
Type 2 diabetes mellitus (T2DM) greatly increases risk for cardiovascular disease, including ischemic heart disease and myocardial infarction. With the completion of several cardiovascular outcomes trials (CVOTs) for new glucose-lowering therapies, including the sodium-glucose cotransporter-2 (SGLT2...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2022-06-01
|
| Collection: | Frontiers in Physiology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fphys.2022.904626/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|